Deep Brain Stimulation Devices Marketembed
Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease.
Deep Brain Stimulation Devices Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease. A patient fitted with a DBS device can get long-term relief from debilitating symptoms of PD. Although some patients may require medications post-surgery, there is significant reduction in side-effects caused due to medications, owing to use of DBS devices. A DBS device is mainly placed in one of the three U.S. Food and Drug Administration (FDA) approved target sites in PD. Most commonly preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN). Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/84 Deep brain stimulation (DBS) device, often described as brain pacemaker, aids in alleviating symptoms of Parkinson’s disease (PD). The device is implanted at one of the three U.S. Food and Drug Administration (FDA) approved brain sites to block the electrical signals from these sites to the brain. The three U.S. FDA approved targeted brain sites are ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN), and globus pallidus pars interna (GPi). DBS surgery is performed on patients suffering from PD for at least four years and are on medications albeit with motor complications. Frequent approval and Launch of novel devices is expected to fuel the global deep brain stimulation devices market growth Key players in the market are focused on approval and launch of novel DBS devices to expand their product portfolio, which is expected to boost the market growth. For instance, in January 2019, Boston Scientific Corporation launched two new DBS devices namely the Vercise Primary Cell (PC) and Vercise Gevia Deep Brain Stimulation (DBS) systems. In June 2015, the U.S. Food and Drug Administration (FDA) approved St. Jude Medical’s Brio Neurostimulation System, a DBS device that helps to reduce symptoms of Parkinson’s disease (PD) and essential tremor. Launch and approval of such novel devices is expected to significantly support the global deep brain stimulation devices market growth over the forecast period. Report includes chapters which deeply display the following deliverable about industry : • Deep Brain Stimulation Devices Market Research Objective and Assumption • Deep Brain Stimulation Devices Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Deep Brain Stimulation Devices Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Deep Brain Stimulation Devices Market, By Regions • Deep Brain Stimulation Devices Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Deep Brain Stimulation Devices Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Deep Brain Stimulation Devices Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Deep Brain Stimulation Devices Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players operating in the global deep brain stimulation devices market include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/84 Detailed Segmentation: • Global Deep Brain Stimulation Devices Market, By Application: • Parkinson's Disease • Essential Tremor • Dystonia • Others • Global Deep Brain Stimulation Devices Market, By End User: • Hospital & Clinics • Ambulatory Surgical Centers • Others • Global Deep Brain Stimulation Devices Market, By Region: • North AmericaEurope • Asia Pacific • Latin America • Middle East • Africa About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]